Bispecific agents: the future of AML and MDS treatment?

It is crucial that drug toxicity is kept as low as possible to improve the quality of life of patients. Speaking from the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by... Author: VJHemOnc Added: 11/23/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts